We welcome PhD student Nicola O’Donnell to ECSG. She brings interesting new research into the needs of teenagers and young adults who have been treated for retinoblastoma in their childhood.

Haematology researchers from York join colleagues in Leeds as part of a multimillion pound funding announcement from the National Institute for Health and Care Research (NIHR).

We are looking for an enthusiastic researcher to work as part of our multi-disciplinary team.

We are looking for an enthusiastic person to work as part of our multi-disciplinary team on the newly formed Cancer Research UK and Blood Cancer UK funded biobank for children and young people with cancer, VIVO Biobank.

Starting a PhD during COVID has brought about many challenges, but with the pandemic subsiding, opportunities previous students have been able to enjoy are now back!

The Universities of York and Newcastle have joined forces with two leading cancer charities to create a new biobank which will provide vital resources for researchers working to prevent, diagnose and treat cancer in children and young people.

Ann Hewison has successfully completed her PhD in ‘Managing treatment and living with chronic myeloid leukaemia’ in 2022, becoming Dr Hewison.

The University of York has been ranked in the top 10 in the UK for the quality of its research, according to a prestigious league table.

Last week saw the first gathering of the York Haematology Support Group since covid.

We are looking for an enthusiastic researcher to work as part of our multi-disciplinary team. We welcome applicants with research interests in epidemiology and statistics, with particular interest in those working in the cancer field.

Exploring the perspectives of patients with chronic blood cancers

We looked at the patterns of genetic mutation in the tumour samples from a large group of patients with follicular lymphoma (FL), and were able to discern three new subclusters.

We tracked survivors of childhood ALL through their teenage and young adult years to see how their health fared

We are delighted to announce a comparison cohort for the Haematological Malignancy Research Network (HMRN).

Understanding, uncertainty and impact in chronic blood cancers